Actinium Pharmaceuticals Inc. (ATNM)
NYSE · Healthcare
Actinium Pharmaceuticals Inc. Shareholder Equity 2010–2025
Actinium Pharmaceuticals Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Actinium Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 7.8M, a 78.47% decrease year-over-year.
- Actinium Pharmaceuticals Inc. shareholder equity for 2025 were 7.8M, a 78.47% decrease from 2023.
- Actinium Pharmaceuticals Inc. shareholder equity for 2023 were 36.4M, a 45.28% decrease from 2022.
- Actinium Pharmaceuticals Inc. shareholder equity for 2022 were 66.5M, a 9.61% decrease from 2021.
- Actinium Pharmaceuticals Inc. shareholder equity for 2021 were 73.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Actinium Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $8 |
| 2023 | $36 |
| 2022 | $66 |
| 2021 | $74 |
| 2011 | $1 |
| 2010 | $0 |
Actinium Pharmaceuticals Inc. Shareholder Equity — FAQ
Actinium Pharmaceuticals Inc. (ATNM) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATNM's shareholder equity history?
The chart and table above show Actinium Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.